Reports

Genome Engineering-China Market Status and Trend Report 2019-2025

Id : 10330 Category : BBC Date : 6-Apr-19 Format : PDF Pages : 130
Report Summary

Genome Engineering-China Market Status and Trend Report 2019-2025 offers a comprehensive analysis on Genome Engineering industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole China and Regional Market Size of Genome Engineering 2013-2017, and development forecast 2018-2023
Main market players of Genome Engineering in China, with company and product introduction, position in the Genome Engineering market
Market status and development trend of Genome Engineering by types and applications
Cost and profit status of Genome Engineering, and marketing status
Market growth drivers and challenges

The report segments the China Genome Engineering market as:

China Genome Engineering Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2019-2025):
North China
Northeast China
East China
Central & South China
Southwest China
Northwest China

China Genome Engineering Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2019-2025):
CRISPR
TALEN
ZFN
Antisense
Other Technologies

China Genome Engineering Market: Application Segment Analysis (Consumption Volume and Market Share 2019-2025; Downstream Customers and Market Analysis)
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Contract Research Organizations
Other Applications

China Genome Engineering Market: Players Segment Analysis (Company and Product introduction, Genome Engineering Sales Volume, Revenue, Price and Gross Margin):
Thermo Fisher Scientific, Inc.
Merck KGaA
Horizon Discovery Group PLC
Genscript USA Inc.
Sangamo Biosciences, Inc.
Integrated DNA Technologies, Inc.
Lonza Group Ltd.
New England Biolabs, Inc.
Origene Technologies, Inc.
Transposagen Biopharmaceuticals, Inc.

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.